Epitomee Medical Ltd

TA:EPIT Israel Medical Devices

Market Cap

$62.18 Million

ILA23.19 Billion ILA

Market Cap Rank

#37234 Global

#274 in Israel

Share Price

ILA771.20

Change (1 day)

+4.01%

52-Week Range

ILA610.70 - ILA1011.00

All Time High

ILA4093.00

Epitomee Medical Ltd - Asset Resilience Ratio

Latest as of June 2025: 0.24%

Epitomee Medical Ltd (EPIT) has an Asset Resilience Ratio of 0.24% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

ILA87.57K

Cash + Short-term Investments

Total Assets

ILA37.04 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how Epitomee Medical Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Epitomee Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ILA0.00	0%
Short-term Investments	ILA87.57K	0.24%
Total Liquid Assets	ILA87.57K	0.24%

Asset Resilience Insights

Limited Liquidity: Epitomee Medical Ltd maintains only 0.24% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.